Fiche centre
Zigong First People's Hospital
Zigong — China
Essais liés3clinical trials
VilleZigonglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06686485
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| FARAPULSE™ PFA system and WATCHMAN LAAC Delivery Systems | Maladie coronarienne | À vérifier | NCT06686485 | OPTION-A — Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia | ACTIVE_NOT_RECRUITING |
| Yangxue Qingnao Granules (Pills) | Migraine | À vérifier | NCT05334927 | CHAIRS — China HeadAche DIsorders RegiStry | RECRUITING |
| Donanemab | Alzheimer | Phase 3 | NCT07571161 | Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease | RECRUITING |